Evidence map›Paper›PMID 16903780›Full record

ReviewPLoS medicine2006

Which topical microbicides for blocking HIV-1 transmission will work in the real world?

Per Johan Klasse, Robin J Shattock, John P Moore

Abstract readReview
In one paragraph

Review in PLoS medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.Journal of acquired immune deficiency syndromes (1999) · 2012
    Article
  10. Article
  11. Article
  12. Animal models for microbicide studies.Current HIV research · 2012
    Review
  13. Liposomes for HIV prophylaxis.Biomaterials · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Per Johan KlasseDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Robin J Shattock
John P Moore

Funding

Evaluation of AFE Inhibitors for Protection from SHIV Vaginal ChallengeU19AI065413 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHATTOCK, ROBIN J · 2005 to 2007
$4.5M
Medical Research Council G0100137NIAID NIH HHS U19 AI065413NIAID NIH HHS U19 AI 65413
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Infective Agents, LocalClinical Trials as TopicDrug Evaluation, PreclinicalHIV-1HIV InfectionsHumansMacacaModels, TheoreticalTreatment OutcomeAnti-Infective Agents, Local

Identifiers

PMID16903780
PMCPMC1539095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.